Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic candidiasis.

T L Ray1

  • 1Department of Dermatology, University of Iowa College of Medicine, Iowa City.

Dermatologic Clinics
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Systemic candidiasis is a growing concern, particularly in immunocompromised patients undergoing cancer treatment. Early diagnosis and effective antifungal drugs are crucial for improving outcomes in these vulnerable individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reassessing reverse triage in future conflict.

BMJ military health·2024
Same author

Rapid and extensive surface changes near Titan's equator: evidence of April showers.

Science (New York, N.Y.)·2011
Same author

Comparison of end-tidal and transcutaneous measures of carbon dioxide during general anaesthesia in severely obese adults.

British journal of anaesthesia·2003
Same author

Structure of secreted aspartic proteinases from Candida. Implications for the design of antifungal agents.

Advances in experimental medicine and biology·1998
Same author

Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents.

Protein science : a publication of the Protein Society·1996
Same author

Cholesterol sulfate protects Candida albicans from inhibition by sphingosine in vitro.

The Journal of investigative dermatology·1996
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Oncology
  • Pharmacology

Background:

  • Systemic candidiasis incidence is rising, linked to modern medical treatments.
  • Immunosuppressive therapies for severe and malignant diseases increase susceptibility to opportunistic fungal infections like candidiasis.
  • Disseminated candidiasis poses significant challenges in neutropenic cancer patients, impacting chemotherapy efficacy.

Purpose of the Study:

  • To highlight the challenges in diagnosing and treating systemic candidiasis in cancer patients.
  • To emphasize the need for improved diagnostic tools and more effective antifungal therapies.

Main Methods:

  • Review of current literature on systemic candidiasis in immunocompromised patients.
  • Analysis of treatment limitations and diagnostic hurdles.

Related Experiment Videos

Main Results:

  • Delayed diagnosis of invasive candidiasis hampers timely antifungal treatment.
  • Limited availability of highly effective, low-toxicity antifungal agents restricts successful treatment.
  • High morbidity and mortality rates associated with systemic candidiasis in neutropenic patients.

Conclusions:

  • Further research into Candida spp. biology is essential.
  • Development of better diagnostic methods is urgently needed.
  • Improved antifungal drugs with reduced toxicity are required for better patient outcomes.